World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN21633644
Date of registration: 26/04/2006
Prospective Registration: No
Primary sponsor: King's College London (UK)
Public title: Can we prevent Crohn's disease: a National study
Scientific title: Assessing and reducing risk of Crohn's disease in smokers
Date of first enrolment: 01/01/2006
Target sample size: 500
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN21633644
Study type:  Interventional
Study design:  Parallel group randomised controlled trial (Treatment)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Theresa M    Marteau
Address:  Health Psychology Section Department of Psychology (at Guy's) 5th Floor Thomas Guy House Guy's Campus SE1 9RT London United Kingdom
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. First degree relatives of patients with Crohn's disease
2. Aged over 18 years
3. Living in the British Isles
4. Without a diagnosis of Crohn's disease or ulcerative colitis
5. Male or female
6. Smoke 5 or more cigarettes daily
7. Able to give informed consent to participate
8. Able to complete, either alone or with assistance, the study questionnaires

Exclusion criteria: Those not meeting the inclusion criteria

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Crohn's disease
Digestive System
Crohn's disease
Intervention(s)
The trial objective is to describe the impact upon motivation to stop smoking of using genotype to assess risk of developing Crohn's disease. We will compare the impact of risk assessment based on family history and DNA testing versus assessment based on family history alone.
Primary Outcome(s)
Current primary outcome as of 28/04/2008:
Stopping smoking for 24 hours or longer in the six months following provision of risk information.

Previous primary outcome:
The proportion of participants in each group engaging in 1 or more quit-related behaviours, measured 6 months after participants are presented with their personalised risk information.
Secondary Outcome(s)
The proportion of participants in each group who make smoking quit attempts of 6 or more days duration. This will be validated using questionnaires and biochemical indices.
Secondary ID(s)
G0500274
Source(s) of Monetary Support
Medical Research Council - Health Services and Public Health Research Board (HSPHRB; ref G0500274) (UK)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history